MX9204880A - Composicion farmaceutica para disminuir los niveles de lipidos en la sangre de los mamiferos - Google Patents

Composicion farmaceutica para disminuir los niveles de lipidos en la sangre de los mamiferos

Info

Publication number
MX9204880A
MX9204880A MX9204880A MX9204880A MX9204880A MX 9204880 A MX9204880 A MX 9204880A MX 9204880 A MX9204880 A MX 9204880A MX 9204880 A MX9204880 A MX 9204880A MX 9204880 A MX9204880 A MX 9204880A
Authority
MX
Mexico
Prior art keywords
mammals
blood
pharmaceutical composition
lipid levels
decrease lipid
Prior art date
Application number
MX9204880A
Other languages
English (en)
Inventor
Georges H Van Den Berghe
Harry E Gruber
Original Assignee
Gensia Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gensia Pharma filed Critical Gensia Pharma
Publication of MX9204880A publication Critical patent/MX9204880A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MX9204880A 1991-08-23 1992-08-21 Composicion farmaceutica para disminuir los niveles de lipidos en la sangre de los mamiferos MX9204880A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74894491A 1991-08-23 1991-08-23
US92975292A 1992-08-12 1992-08-12

Publications (1)

Publication Number Publication Date
MX9204880A true MX9204880A (es) 1993-04-01

Family

ID=27115023

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9204880A MX9204880A (es) 1991-08-23 1992-08-21 Composicion farmaceutica para disminuir los niveles de lipidos en la sangre de los mamiferos

Country Status (7)

Country Link
EP (1) EP0599987A4 (es)
AU (1) AU2486192A (es)
CA (1) CA2115675A1 (es)
IL (1) IL102895A0 (es)
MX (1) MX9204880A (es)
NO (1) NO940580L (es)
WO (1) WO1993003734A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1492564A2 (en) * 2001-10-31 2005-01-05 Université Libre de Bruxelles Amp-kinase agonists or adenosine pro-drugs as immuno-stimulating agents
ES2192495B1 (es) 2002-03-21 2005-02-16 Universidad De Barcelona Nuevo uso terapeutico del ribosido de 5-aminoimidazol-4-carboxamida (acadesina).
US8895520B2 (en) 2011-10-26 2014-11-25 Universite Nice Sophia Antipolis Method for treating a human patent suffering from Myeloid Neoplasias using 5-aminoimidazole-4-carboxamide
MY182801A (en) * 2013-09-26 2021-02-05 Energenesis Biomedical Co Ltd Compound for activating ampk and uses thereof
JP7376951B2 (ja) 2018-08-06 2023-11-09 スカイラーク バイオサイエンス エルエルシー Amp活性化プロテインキナーゼ活性化化合物およびその使用
US11779590B2 (en) 2020-10-30 2023-10-10 Skylark Bioscience Llc AMP-activated protein kinase activating compounds and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2026040C3 (de) * 1970-05-27 1975-09-18 Boehringer Mannheim Gmbh, 6800 Mannheim Imidazolribosylcyclophosphate
US3919192A (en) * 1972-05-22 1975-11-11 Icn Pharmaceuticals 5-Amino-4-substituted imidazole nucleotides
US4575498A (en) * 1983-07-21 1986-03-11 Duke University Method for restoring depleted purine nucleotide pools
US4912092A (en) * 1986-03-27 1990-03-27 The Regents Of The University Of California Methods for increasing extracellular adenosine and for stabilizing mast cells

Also Published As

Publication number Publication date
AU2486192A (en) 1993-03-16
IL102895A0 (en) 1993-01-31
EP0599987A4 (en) 1995-02-01
NO940580L (no) 1994-04-25
NO940580D0 (no) 1994-02-21
WO1993003734A1 (en) 1993-03-04
EP0599987A1 (en) 1994-06-08
CA2115675A1 (en) 1993-03-04

Similar Documents

Publication Publication Date Title
MX9207222A (es) Procedimiento para la preparacion de compuestos farmaceuticos que reducen selectivamente el nivel de lipidos de la sangre.
MX159428A (es) Conjunto de bisturi para extraer sangre
ES281482Y (es) Soporte para pisar
DK73688A (da) Flydende enzymformuleringer
DE122004000023I2 (de) Pharmazeutische Zusammensetzung
ES541650A0 (es) Perfeccionamientos en los tobillos biomecanicos para pies artificiales
MX9204880A (es) Composicion farmaceutica para disminuir los niveles de lipidos en la sangre de los mamiferos
ES547033A0 (es) Perfeccionamientos en los dispositivos para la aplicacion demasas cosmeticas
MC1878A1 (fr) Compositions pharmaceutiques
ES548133A0 (es) Perfeccionamientos en los aparatos de cinesiterapia para la resolucion de las anomalias de rodilla
MX174530B (es) Derivados de tripeptidos, procedimientos para la preparacion de derivados de tripeptidos y composiciones que los contienen
DK504187D0 (da) Farmaceutisk praeparat indeholdende mindst en lipidregulator
ES544824A0 (es) Procedimiento para la preparacion de ester tercibutilico de norcarnitina
ES550282A0 (es) Procedimiento para la preparacion de a-l-aspartil-l-fenila- lanina metil ester
ATA133288A (de) Pharmazeutische zusammensetzung
IT1222735B (it) Composizioni farmaceutiche laminate transdermali ad effetto prolungato e procedimento per la loro preparazione
IT8847657A0 (it) Procedimento per la preparazione di derivati stilbenici contenenti gruppi triazinile
ITMI911445A1 (it) Impiego di derivati fosfolipidici per la preparazione di composizioni farmaceutiche aventi attivita' immunosoppressiva
MX9206685A (es) Procedimiento para la preparacion de adipatos de alquilo
MX9101959A (es) Procedimiento para la preparacion de trioxano
RO91976A2 (ro) Compozitie medicamentoasa cu vitamine sub forma de tablete turnate
ES550320A0 (es) Perfeccionamientos en los procedimientos de preparacion de lubricantes para compresores
ES2053432T3 (es) Azapropazona para la prevencion de lesiones post-isquemicas de los tejidos.
ES528903A0 (es) Mejoras introducidas en los mecanismos para movimiento de extremidades en los munecos
ES293533Y (es) Estructura reticular para la formacion de bancadas para maquinaria